NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ADC Development Panel, a specialized gene…